Polyneuron Pharmaceuticals AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.polyneuron.com
Clinical Trials
4
Active:2
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
- First Posted Date
- 2020-09-29
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Polyneuron Pharmaceuticals AG
- Target Recruit Count
- 1
- Registration Number
- NCT04568174
- Locations
- 🇫🇷
Service de Neurologie Centre de Référence Neuropathies Périphériques Rares, CHU Limoges, Limoges, France
🇫🇷Referral centre for neuromuscular diseases and ALS, hôpital La Timone, Marseille, France
🇫🇷Département de Neurologie Pôle Neurosciences Centre de Référence des Neuropathies Amyloïdes Familiales et autres Neuropathies Périphériques Rares Centre Hospitalier Universitaire de Bicêtre, Paris, France
News
No news found